Paramount Bed Holdings Co., Ltd.
Paramount Bed Holdings Co., Ltd. (7817.T) Stock Competitors & Peer Comparison
See (7817.T) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 7817.T | ¥3,515.00 | +0.00% | 197.1B | 0.00 | ¥2,596,818,940.00 | +3.16% |
| 7741.T | ¥29,490.00 | +1.74% | 10T | 48.53 | ¥607.71 | +0.88% |
| 4543.T | ¥2,139.00 | -1.47% | 3.2T | 24.15 | ¥88.58 | +1.40% |
| 7733.T | ¥1,568.50 | -1.26% | 1.7T | 18.16 | ¥86.35 | +1.91% |
| 7747.T | ¥3,533.00 | -1.83% | 937.4B | 53.30 | ¥66.29 | +0.69% |
| 6869.T | ¥1,388.00 | -1.32% | 865B | 18.55 | ¥74.84 | +2.74% |
| 8086.T | ¥1,634.50 | +0.03% | 266.6B | 27.62 | ¥59.17 | +1.71% |
| 7716.T | ¥2,865.00 | +0.28% | 237.9B | -99.86 | -¥28.69 | +1.69% |
| 3360.T | ¥2,465.00 | -1.68% | 226.8B | 15.44 | ¥159.67 | +2.43% |
| 7730.T | ¥1,533.00 | -0.78% | 151B | 32.51 | ¥47.16 | +2.61% |
Stock Comparison
7817.T vs 7741.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 7741.T has a market cap of 10T. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 7741.T trades at ¥29,490.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 7741.T's P/E ratio is 48.53. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7741.T's ROE of +0.25%. Regarding short-term risk, 7817.T is less volatile compared to 7741.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 7741.T's competition here
7817.T vs 4543.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 4543.T has a market cap of 3.2T. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 4543.T trades at ¥2,139.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 4543.T's P/E ratio is 24.15. In terms of profitability, 7817.T's ROE is +0.07%, compared to 4543.T's ROE of +0.09%. Regarding short-term risk, 7817.T is less volatile compared to 4543.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 4543.T's competition here
7817.T vs 7733.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 7733.T has a market cap of 1.7T. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 7733.T trades at ¥1,568.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 7733.T's P/E ratio is 18.16. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7733.T's ROE of +0.11%. Regarding short-term risk, 7817.T is less volatile compared to 7733.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 7733.T's competition here
7817.T vs 7747.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 7747.T has a market cap of 937.4B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 7747.T trades at ¥3,533.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 7747.T's P/E ratio is 53.30. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7747.T's ROE of +0.12%. Regarding short-term risk, 7817.T is less volatile compared to 7747.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 7747.T's competition here
7817.T vs 6869.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 6869.T has a market cap of 865B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 6869.T trades at ¥1,388.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 6869.T's P/E ratio is 18.55. In terms of profitability, 7817.T's ROE is +0.07%, compared to 6869.T's ROE of +0.09%. Regarding short-term risk, 7817.T is less volatile compared to 6869.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 6869.T's competition here
7817.T vs 8086.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 8086.T has a market cap of 266.6B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 8086.T trades at ¥1,634.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 8086.T's P/E ratio is 27.62. In terms of profitability, 7817.T's ROE is +0.07%, compared to 8086.T's ROE of +0.06%. Regarding short-term risk, 7817.T is less volatile compared to 8086.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 8086.T's competition here
7817.T vs 7716.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 7716.T has a market cap of 237.9B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 7716.T trades at ¥2,865.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 7716.T's P/E ratio is -99.86. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7716.T's ROE of -0.02%. Regarding short-term risk, 7817.T is less volatile compared to 7716.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 7716.T's competition here
7817.T vs 3360.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 3360.T has a market cap of 226.8B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 3360.T trades at ¥2,465.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 3360.T's P/E ratio is 15.44. In terms of profitability, 7817.T's ROE is +0.07%, compared to 3360.T's ROE of +0.10%. Regarding short-term risk, 7817.T is less volatile compared to 3360.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 3360.T's competition here
7817.T vs 7730.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 7730.T has a market cap of 151B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 7730.T trades at ¥1,533.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 7730.T's P/E ratio is 32.51. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7730.T's ROE of +0.11%. Regarding short-term risk, 7817.T is less volatile compared to 7730.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 7730.T's competition here
7817.T vs 3593.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 3593.T has a market cap of 143.4B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 3593.T trades at ¥6,650.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 3593.T's P/E ratio is 227.27. In terms of profitability, 7817.T's ROE is +0.07%, compared to 3593.T's ROE of +0.00%. Regarding short-term risk, 7817.T is less volatile compared to 3593.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 3593.T's competition here
7817.T vs 7780.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 7780.T has a market cap of 127.5B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 7780.T trades at ¥1,720.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 7780.T's P/E ratio is 25.77. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7780.T's ROE of +0.08%. Regarding short-term risk, 7817.T is less volatile compared to 7780.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 7780.T's competition here
7817.T vs 3046.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 3046.T has a market cap of 125.3B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 3046.T trades at ¥5,370.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 3046.T's P/E ratio is 15.04. In terms of profitability, 7817.T's ROE is +0.07%, compared to 3046.T's ROE of +0.28%. Regarding short-term risk, 7817.T is less volatile compared to 3046.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 3046.T's competition here
7817.T vs 7979.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 7979.T has a market cap of 62.5B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 7979.T trades at ¥1,755.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 7979.T's P/E ratio is 13.76. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7979.T's ROE of +0.10%. Regarding short-term risk, 7817.T is less volatile compared to 7979.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 7979.T's competition here
7817.T vs 368A.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 368A.T has a market cap of 53.4B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 368A.T trades at ¥1,334.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 368A.T's P/E ratio is 13.72. In terms of profitability, 7817.T's ROE is +0.07%, compared to 368A.T's ROE of N/A. Regarding short-term risk, 7817.T is less volatile compared to 368A.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 368A.T's competition here
7817.T vs 5889.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 5889.T has a market cap of 51B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 5889.T trades at ¥2,113.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 5889.T's P/E ratio is 13.68. In terms of profitability, 7817.T's ROE is +0.07%, compared to 5889.T's ROE of +0.22%. Regarding short-term risk, 7817.T is less volatile compared to 5889.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 5889.T's competition here
7817.T vs 7749.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 7749.T has a market cap of 43.2B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 7749.T trades at ¥2,981.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 7749.T's P/E ratio is 14.16. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7749.T's ROE of +0.07%. Regarding short-term risk, 7817.T is less volatile compared to 7749.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 7749.T's competition here
7817.T vs 3154.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 3154.T has a market cap of 18.4B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 3154.T trades at ¥826.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 3154.T's P/E ratio is 13.56. In terms of profitability, 7817.T's ROE is +0.07%, compared to 3154.T's ROE of +0.07%. Regarding short-term risk, 7817.T is less volatile compared to 3154.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 3154.T's competition here
7817.T vs 7743.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 7743.T has a market cap of 18.3B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 7743.T trades at ¥603.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 7743.T's P/E ratio is 13.27. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7743.T's ROE of +0.06%. Regarding short-term risk, 7817.T is less volatile compared to 7743.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 7743.T's competition here
7817.T vs 7775.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 7775.T has a market cap of 12.9B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 7775.T trades at ¥449.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 7775.T's P/E ratio is 12.88. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7775.T's ROE of +0.13%. Regarding short-term risk, 7817.T is less volatile compared to 7775.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 7775.T's competition here
7817.T vs 3446.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 3446.T has a market cap of 11.9B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 3446.T trades at ¥2,020.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 3446.T's P/E ratio is 130.58. In terms of profitability, 7817.T's ROE is +0.07%, compared to 3446.T's ROE of +0.03%. Regarding short-term risk, 7817.T is less volatile compared to 3446.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 3446.T's competition here
7817.T vs 7702.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 7702.T has a market cap of 10.6B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 7702.T trades at ¥431.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 7702.T's P/E ratio is 67.13. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7702.T's ROE of -0.01%. Regarding short-term risk, 7817.T is less volatile compared to 7702.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 7702.T's competition here
7817.T vs 4556.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 4556.T has a market cap of 9.5B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 4556.T trades at ¥2,265.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 4556.T's P/E ratio is 15.93. In terms of profitability, 7817.T's ROE is +0.07%, compared to 4556.T's ROE of +0.09%. Regarding short-term risk, 7817.T is more volatile compared to 4556.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.Check 4556.T's competition here
7817.T vs 3604.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 3604.T has a market cap of 6.9B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 3604.T trades at ¥1,198.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 3604.T's P/E ratio is 15.04. In terms of profitability, 7817.T's ROE is +0.07%, compared to 3604.T's ROE of +0.05%. Regarding short-term risk, 7817.T is less volatile compared to 3604.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 3604.T's competition here
7817.T vs 9340.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 9340.T has a market cap of 6.7B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 9340.T trades at ¥688.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 9340.T's P/E ratio is 14.48. In terms of profitability, 7817.T's ROE is +0.07%, compared to 9340.T's ROE of +0.16%. Regarding short-term risk, 7817.T is less volatile compared to 9340.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 9340.T's competition here
7817.T vs 7980.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 7980.T has a market cap of 6.5B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 7980.T trades at ¥910.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 7980.T's P/E ratio is 11.38. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7980.T's ROE of +0.08%. Regarding short-term risk, 7817.T is less volatile compared to 7980.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 7980.T's competition here
7817.T vs 7782.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 7782.T has a market cap of 3B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 7782.T trades at ¥462.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 7782.T's P/E ratio is 11.35. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7782.T's ROE of +0.10%. Regarding short-term risk, 7817.T is less volatile compared to 7782.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.Check 7782.T's competition here
7817.T vs 7813.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 7813.T has a market cap of 2.8B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 7813.T trades at ¥837.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 7813.T's P/E ratio is 15.83. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7813.T's ROE of +0.06%. Regarding short-term risk, 7817.T is more volatile compared to 7813.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.Check 7813.T's competition here
7817.T vs 7090.T Comparison April 2026
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 197.1B. In comparison, 7090.T has a market cap of 1.5B. Regarding current trading prices, 7817.T is priced at ¥3,515.00, while 7090.T trades at ¥1,002.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 0.00, whereas 7090.T's P/E ratio is -5.51. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7090.T's ROE of -1.52%. Regarding short-term risk, 7817.T is more volatile compared to 7090.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.Check 7090.T's competition here